Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2023-04-16 AGM Information
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
2022年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a short announcement (1014 characters) about a scheduled performance explanation meeting related to the company's 2022 Annual Report. It references the 2022 Annual Report published earlier (announcement number 2023-013) and invites investors to participate in a web-based meeting to discuss the report. The document does not contain the actual annual report or detailed financial data but rather announces the upcoming meeting to explain the annual report results. According to the 'Menu vs Meal' rule, this is an announcement about a report-related event, not the report itself. Therefore, the appropriate classification is AGM Information (AGM-R), as it relates to materials shared during an annual general meeting or similar shareholder meeting event focused on the annual report.
2023-04-16 Chinese
关于使用闲置募集资金暂时补充流动资金归还的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (611 characters) regarding the company's use of idle raised funds temporarily supplementing working capital and the subsequent repayment of those funds. It references a previous board meeting decision and the return of funds to the designated account. There is no detailed financial data or comprehensive report content. The document serves as an update on capital usage and repayment, fitting the description of a Capital/Financing Update rather than a full financial report or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-04-16 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is titled as an "Information Disclosure Management System" issued by the company's board. It details the company's policies, procedures, responsibilities, and legal compliance related to information disclosure, including definitions of periodic and interim reports, disclosure principles, and internal controls. It does not contain any financial statements, audit opinions, earnings data, or meeting results. Instead, it is a governance-related document outlining internal rules and practices for information disclosure. Therefore, it fits best under Governance Information (CGR). The document length (9349 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2023-03-30 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告 2022' which translates to 'Annual Report 2022'. It contains detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management details, industry information, corporate governance, internal controls, and financial accounting reports. The document includes audited financial statements, management's discussion and analysis, risk disclosures, and detailed financial metrics for the fiscal year 2022. The length of the document (15,000 characters) and the comprehensive content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-03-30 Chinese
2022年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Directors' Report for the Year 2022" from Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the independent directors' attendance at board and shareholder meetings, their opinions on various company matters, and their efforts to protect investor rights during the 2022 fiscal year. The content focuses on the independent directors' duties, opinions, and compliance with regulations rather than presenting full financial statements or audit results. The document length is 2529 characters, which is relatively short and more consistent with a report or statement rather than a full annual or interim report. It is not an announcement of a report publication but a substantive report on independent directors' activities and opinions. This type of document aligns best with the category of Board/Management Information (MANG), as it relates to governance and management oversight activities rather than financial results or audit reports.
2023-03-30 Chinese
独立董事关于第三届董事会第二十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several board meeting agenda items, including the 2023 director and senior management remuneration plans, the 2022 profit distribution plan, and the proposal to reappoint the audit firm for 2023. It references the board meeting (third board, 22nd meeting) and discusses approval of remuneration and audit firm reappointment. The document is a formal opinion statement from independent directors rather than a full report or financial statement. It does not contain financial data or detailed financial results, nor is it a simple announcement of a report. It is related to board/management information, specifically about remuneration and audit firm appointment, which fits best under Board/Management Information (MANG).
2023-03-30 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.